Top Markets
Coin of the day
Kailera Therapeutics, Inc. Kailera Therapeutics, Inc.

Kailera Therapeutics, Inc.

KLRA
Clasificación en acciones #5958
Kailera Therapeutics is a biopharmaceutical company currently advancing through... Kailera Therapeutics is a biopharmaceutical company currently advancing through its clinical development stage, dedicated to cultivating a varied portfolio of cutting-edge treatments. These therapeutics are specifically engineered to tackle obesity and its associated metabolic disorders. The company distinguishes itself through its focus on innovative methodologies, offering both injectable and orally administered formulations for sustainable weight management. Its most advanced candidate is a groundbreaking dual-action gut hormone receptor agonist, which has reported encouraging outcomes in its initial clinical investigations.
Precio por acción
$18.55
Capitalización bursátil
$2.40B
Cambio (1 día)
0.60%
Cambio (1 año)
-
País
US
Comercio Kailera Therapeutics, Inc. (KLRA)

Categoría

Historial del precio de la acción de Kailera Therapeutics, Inc. (KLRA)
Precio más alto de cierre: $18.16 el 2026-08-01

Precio más bajo de cierre: $24.48 el 2026-04-01
Historial del precio de la acción de Kailera Therapeutics, Inc. desde 2026 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
Not enough data for the provided dates.
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$550.37 41.45%
US
$1.05K 48.82%
NL
$122.63 -12.65%
AU
$139.86 457.21%
US
$765.77 7.27%
CH